Wei Wang

China Everbright Group Ltd. engages in the operation of financial business. Its business scope covers finance, investment, industrial, and technology segments. Its Finance division covers banking, securities, insurance, trust, fund, leasing, and futures businesses. Its Investment division provides asset management and investment services. Its Industrial division consists of environmental protection, travel, health, pension services, and real estate properties businesses. Its Technology division offers cloud payment platform, face recognition intelligent access control, and data intelligence analysis platform. The company was founded in on August 18, 1983 and is headquartered in Beijing, China.

Chong Sing Holdings FinTech Group Ltd. operates as an investment holding company, which engages in the provision of consultancy and online financial services through Internet and mobile solutions. It operates through the following segments: Traditional Loans and Loans Financing, Third Party Payment Service, Online Investment and Technology Enabled Lending, Blockchain Services, and Others. The Traditional Loans and Loans Financing segment provides financing services in China and Hong Kong. The Third Party Payment Service segment engages in the provision of online third party payment services and prepaid card issuance business. The Online Investment and Technology Enabled Lending segment provides Internet loan financing service in China. The Blockchain Services segment provides transaction verification services in Hong Kong, Canada and Georgia. The Others segment provides social gaming services in the PRC, IT solution services in Vietnam, and exhibition services in Hong Kong and PRC. The company was founded in June 2003 and is headquartered in Shanghai, China.

Shanghai City Investment Holdings Co. Ltd. is an investment holding private company based in Shanghai, China.

Huayuan Real Estate Co. Ltd. provides real estate services. The private company is based in Guangdong, China.

Shanghai Benemae Pharmaceutical Corp. engages in the research, development, and distribution of biopharmaceuticals in the fields of endocrinology, cardiology, and oncology. Its products include diabetes medicine, obesity treatment products, fatty liver medication, and hepatitis treatment products. The company was founded on January 12, 1999 and is headquartered in Shanghai, China.